ePA (the need for standard data exchange) may inform global drug coverage platforms
Get scouting reports, video, stats, projected ETAs and more for Boston's Top 30 Prospects
The Use of Medium-Chain Triglyceridesin Gastrointestinal Disorders
Medical weight loss programs in Florida focus on individual health history, goals, and ongoing monitoring to determine whether continued participation remains appropriate over time
Christopher McGowan, M.D., an obesity medicine specialist, states that tirzepatide may be more effective for weight loss due to its synergistic effects, targeting GLP-1 and GIP receptors
Notably, tirzepatide can reduce oral contraceptive exposure, and backup non-oral or barrier contraception is recommended for 4 weeks after initiation and each dose increase